Back to Blog

Supplements for Eye Health: Protecting Vision as You Age

February 26, 2026·7 min read

Visual health supplements are one area of the market where there is genuinely strong, clinically validated evidence—largely because age-related macular degeneration (AMD) research has been funded and rigorously conducted by the National Eye Institute over decades. The AREDS and AREDS2 trials set a high bar for what we know about eye-specific supplementation.

Beyond AMD, emerging evidence supports specific nutrients for dry eye disease, digital eye strain, and general macular health. Understanding which supplements work for which conditions—and for whom—is essential for making intelligent choices.

The AREDS2 Formula: The Evidence-Based Standard for AMD

Age-related macular degeneration is the leading cause of irreversible central vision loss in adults over 50. The original AREDS (Age-Related Eye Disease Study) trial found that a specific formula of Vitamin C (500 mg), Vitamin E (400 IU), beta-carotene (15 mg), and zinc (80 mg with copper 2 mg) reduced the risk of AMD progression by approximately 25% in people with intermediate AMD or advanced AMD in one eye.

AREDS2 updated the formula by replacing beta-carotene (which was found to increase lung cancer risk in smokers) with lutein 10 mg + zeaxanthin 2 mg, and reducing the zinc dose to 25 mg. The AREDS2 formula—lutein 10 mg, zeaxanthin 2 mg, Vitamin C 500 mg, Vitamin E 400 IU, zinc 25 mg, copper 2 mg—is now the evidence-based standard.

Critical caveat: the AREDS2 formula is proven only for people with intermediate to advanced AMD. It is not proven to prevent AMD from developing in people without the condition, and it should not be marketed or used as general eye protection for everyone. If you have diagnosed AMD or a family history with documented intermediate AMD, the AREDS2 formula is appropriate and evidence-based. For others, a lower-dose lutein/zeaxanthin supplement without the high-dose Vitamin C/E/zinc may be more appropriate.

Lutein and Zeaxanthin: Macular Pigment and Screen Protection

Lutein and zeaxanthin are the only carotenoids concentrated in the macula—the central high-acuity region of the retina. They form the "macular pigment" that filters short-wavelength (blue) light and quenches reactive oxygen species generated by light exposure in photoreceptors.

Beyond their role in AMD, lutein and zeaxanthin are relevant for:

Digital eye strain: Multiple trials have found that lutein and zeaxanthin supplementation improves contrast sensitivity, reduces glare sensitivity, and decreases visual fatigue from extended screen use. A 2017 RCT found significant improvement in sleep quality and visual performance measures in young adults supplementing lutein/zeaxanthin over 6 months.

General macular health: Even in people without AMD, macular pigment optical density is inversely correlated with visual aging and can be increased with supplementation. Doses of 10–20 mg lutein and 2–4 mg zeaxanthin are used in most trials.

Lutein is found in leafy green vegetables (kale, spinach) but most people do not consume adequate amounts. Food-based intake is preferred when feasible; supplementation fills the gap.

Omega-3 Fatty Acids: The Evidence-Based Treatment for Dry Eye

Dry eye disease is one of the most prevalent eye conditions, affecting over 16 million Americans. Omega-3 fatty acids—particularly EPA and DHA—are among the best-supported interventions.

DHA is actually a structural component of retinal photoreceptor membranes, making it directly relevant to retinal function. EPA and DHA also modulate the inflammatory processes that drive meibomian gland dysfunction (the most common cause of evaporative dry eye). Multiple RCTs show that omega-3 supplementation significantly improves dry eye symptoms, tear film stability, and meibomian gland function.

The DREAM (Dry Eye Assessment and Management) trial in 2018 found that high-dose omega-3 (3,000 mg EPA+DHA refined fish oil) did not outperform olive oil placebo—a surprising negative result that generated significant discussion. However, several subsequent meta-analyses concluded that when considering the full RCT evidence, omega-3 supplementation does significantly improve dry eye symptoms. The DREAM trial had methodological limitations including an active placebo. Dose: 2–3 g/day EPA+DHA.

Astaxanthin: Eye Fatigue and Intraocular Blood Flow

Astaxanthin is a red carotenoid from algae (concentrated in krill and salmon) that crosses the blood-retinal barrier and has potent antioxidant activity—approximately 550 times stronger than Vitamin E in singlet oxygen quenching. Japanese clinical trials have found that astaxanthin supplementation at 6 mg/day reduces eye fatigue and improves accommodation recovery speed (the eye's ability to rapidly refocus between distances—the primary mechanism of digital eye strain).

A 2005 RCT by Nagaki et al. found that 6 mg/day of astaxanthin significantly improved accommodation amplitude and reduced subjective eye fatigue after 4 weeks in computer workers. Astaxanthin is particularly relevant for people with significant screen time.

Vitamin A: Night Vision and Photoreceptor Function

Vitamin A (as retinol) is the precursor to rhodopsin—the light-sensitive pigment in rod photoreceptors that enables scotopic (night/dim light) vision. Severe Vitamin A deficiency causes night blindness and eventually xerophthalmia. True deficiency is rare in developed countries but can occur in malabsorption conditions, very low-fat diets, or alcoholism.

Supplementing Vitamin A above needs does not improve vision in replete individuals—it is a correction for deficiency, not an enhancement. Moreover, excess preformed Vitamin A (retinol) is fat-soluble and accumulates to toxic levels; the tolerable upper limit is 10,000 IU/day for adults.

Bilberry: Traditional Use with Limited Strong Evidence

Bilberry (European blueberry) extract became associated with improved night vision after British RAF pilots in WWII allegedly ate bilberry jam and reported improved vision. The controlled evidence is much weaker than the story implies—RCTs have generally not confirmed significant improvements in visual acuity or night vision in healthy individuals.

Bilberry anthocyanins do have genuine antioxidant and anti-inflammatory effects relevant to retinal health, and some studies suggest benefits for eye fatigue similar to astaxanthin. As a complementary antioxidant for general retinal protection, it is reasonable; for specific vision enhancement, the evidence is insufficient.

Blue Light Glasses vs. Supplements

Blue light blocking glasses have become enormously popular for screen use. The scientific consensus is that artificial blue light from screens is not a significant source of retinal damage at typical screen brightness levels, and blue light glasses do not improve dry eye symptoms or visual acuity significantly in trials. They may help with sleep (blue light in the evening suppresses melatonin) but their eye health benefits specifically are overstated.

Lutein/zeaxanthin supplements, omega-3 fatty acids, and astaxanthin have more rigorous evidence for the actual mechanisms of digital eye strain than blue light glasses.

FAQ

Should everyone over 50 take AREDS2 supplements? No. AREDS2 is specifically designed for people with intermediate AMD or advanced AMD in one eye. Taking the full AREDS2 formula without AMD risk factors exposes you to high-dose Vitamin E (which has its own concerns at 400 IU/day) and high-dose zinc without proven benefit for prevention. Have an annual dilated eye exam so AMD can be detected and staged if present.

Can lutein/zeaxanthin supplements reverse existing macular damage? No supplement reverses existing retinal damage. Lutein and zeaxanthin support the remaining photoreceptors, build macular pigment protection against future damage, and reduce AMD progression—they cannot regenerate cells that have already been lost.

Is astaxanthin the same as beta-carotene or lycopene? All three are carotenoids but structurally and functionally different. Astaxanthin is a xanthophyll (like lutein and zeaxanthin) rather than a carotene (like beta-carotene and lycopene). Astaxanthin's unique molecular structure allows it to span the full width of a cell membrane, providing end-to-end antioxidant protection—a property not shared by the carotenes.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free